Successful combination therapy with vancomycin and arbekacin against infective endocarditis caused by MRSA

Kentaro To; Noriko Miyake; Yoji Nagasaki; Nobuyuki Shimono

Successful combination therapy with vancomycin and arbekacin against infective endocarditis caused by MRSA

Kentaro To, Noriko Miyake, Yoji Nagasaki, Nobuyuki Shimono

研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

抄録

Infective endocarditis caused by methicillin-resistant Staphylococcus aureus (MRSA) is a serious disease and sometimes leads to poor prognosis. We should have several therapeutic options. Arbekacin is one of the aminoglycoside antibiotics, which is more active against MRSA and less nephrotoxic than gentamicin. Here we presented a successfully treated case of severe MRSA endocarditis without any adverse effect by monitoring therapeutic level of vancomycin and arbekacin.

本文言語	英語
ページ（範囲）	389-394
ページ数	6
ジャーナル	Japanese Journal of Antibiotics
巻	64
号	6
出版ステータス	出版済み - 12月 1 2011

!!!All Science Journal Classification (ASJC) codes

微生物学（医療）
薬理学（医学）
感染症

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

他のファイルとリンク

引用スタイル

@article{d6030c624eee4e64a9f6dd6c4b9562bc,

title = "Successful combination therapy with vancomycin and arbekacin against infective endocarditis caused by MRSA",

abstract = "Infective endocarditis caused by methicillin-resistant Staphylococcus aureus (MRSA) is a serious disease and sometimes leads to poor prognosis. We should have several therapeutic options. Arbekacin is one of the aminoglycoside antibiotics, which is more active against MRSA and less nephrotoxic than gentamicin. Here we presented a successfully treated case of severe MRSA endocarditis without any adverse effect by monitoring therapeutic level of vancomycin and arbekacin.",

author = "Kentaro To and Noriko Miyake and Yoji Nagasaki and Nobuyuki Shimono",

year = "2011",

month = dec,

day = "1",

language = "English",

volume = "64",

pages = "389--394",

journal = "The Journal of antibiotics. Ser. B",

issn = "0368-2781",

publisher = "Japan Antibiotics Research Association",

number = "6",

}

TY - JOUR

T1 - Successful combination therapy with vancomycin and arbekacin against infective endocarditis caused by MRSA

AU - To, Kentaro

AU - Miyake, Noriko

AU - Nagasaki, Yoji

AU - Shimono, Nobuyuki

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Infective endocarditis caused by methicillin-resistant Staphylococcus aureus (MRSA) is a serious disease and sometimes leads to poor prognosis. We should have several therapeutic options. Arbekacin is one of the aminoglycoside antibiotics, which is more active against MRSA and less nephrotoxic than gentamicin. Here we presented a successfully treated case of severe MRSA endocarditis without any adverse effect by monitoring therapeutic level of vancomycin and arbekacin.

AB - Infective endocarditis caused by methicillin-resistant Staphylococcus aureus (MRSA) is a serious disease and sometimes leads to poor prognosis. We should have several therapeutic options. Arbekacin is one of the aminoglycoside antibiotics, which is more active against MRSA and less nephrotoxic than gentamicin. Here we presented a successfully treated case of severe MRSA endocarditis without any adverse effect by monitoring therapeutic level of vancomycin and arbekacin.

UR - http://www.scopus.com/inward/record.url?scp=84856173794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856173794&partnerID=8YFLogxK

M3 - Article

C2 - 22686009

AN - SCOPUS:84856173794

SN - 0368-2781

VL - 64

SP - 389

EP - 394

JO - The Journal of antibiotics. Ser. B

JF - The Journal of antibiotics. Ser. B

IS - 6

ER -

Successful combination therapy with vancomycin and arbekacin against infective endocarditis caused by MRSA

抄録

!!!All Science Journal Classification (ASJC) codes

UN SDG

他のファイルとリンク

フィンガープリント

引用スタイル